XORTX is a biopharmaceutical company focused on developing drugs that could reduce serum acid uric levels. An Initiation Equity Research Report on XORTX was published by eResearch on August 16, 2020. [more]
Last month Amwell and GoodRx, two telehealth-focused companies, listed publicly through IPOs. Amwell raised $922M with a current market cap of $7.8B, while GoodRx raised $1.3B with a current market cap of $20B. [more]
In September, CloudMD announced a series of acquisitions to expand its telehealth services. CloudMD spent approximately $19M on three acquisitions, including Benchmark Systems, iMD Health Global, and Snapclarity. [more]
Earlier this month, Loblaw, through its subsidiary Shoppers, announced a $75M minority stake investment in Maple, a Canadian telemedicine company. The acquisition is expected to expand Shoppers’ virtual healthcare services across Canada. [more]
In an effort to improve services for patients, healthcare companies are focusing on acquiring and developing AI technologies to enhance administrative and operational capabilities. Last year, global AI venture capital investments in the healthcare and pharmaceutical sector reached $2.4B compared with $1B in the prior year. [more]
The enterprise Big Data & Analytics company was founded by billionaire investor Peter Thiel and Dr. Alex Karp. The Company expects to bill $1B in revenue in 2020 and be profitable. Verticals include defense and intelligence agencies, including the CIA, energy, financial services, healthcare, manufacturing and transportation sectors. [more]
New 33-page Initiation Equity Research Report on XORTX, with a Speculative Buy rating and one-year price target of $2.30/share. The Company has two potential late stage drugs in development focused on kidney diseases that could initiate pivotal Phase 3 clinical trials in the next 12 months. [more]
Recently, the Trump administration ordered more than 500,000 doses of Remdesivir, fully clearing out Gilead’s supply for July and taking 90% of Gilead’s production in August and September, leaving no supply for the rest of the world. [more]
As U.S. States & Canadian Provinces announce plans to ease restrictions, testing and vaccines for COVID-19 gain importance. Canadian healthcare companies developing vaccines and tests for COVID-19: LexaGene, Microbix Biosciences, SQI Diagnostics, IMV, Protech Home Medical, and Viemed Healthcare. [more]
The pharmaceutical industry in developing vaccines, treatments, and tests. Companies such as Abbott, Amgen, Arcturus, Bayer, La Roche Holdings, Novartis, Pfizer, and Thermo Fisher are leading the way. [more]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes